Mrs
Karen
Russell

Senior Patent Attorney

Manchester Office

Telephone. +44(0) 161 247 4900
Email. [email protected]

Experience

Bringing over 20 years’ experience in private practice, Karen specialises in the fields of life sciences and pharmaceuticals. Having started her career in London, she joined HGF in 2010 and enjoys being an active member of the biotech and chemical teams in the Manchester office.

Karen’s experience covers a wide range of biotechnological and biopharmaceutical subject matter including nucleic acid and peptide based therapeutics. She has a particular interest in SPCs, and her practice includes filing and prosecution of SPC applications in both the medicinal and agrochemical fields.

In the course of her career, she has worked with a variety of clients, including universities, SMEs and large multi-nationals, providing guidance in patent prosecution before the EPO and internationally, as well as advice relating to patentability, freedom to operate, and SPC filings.

Karen holds an MA in Natural Sciences (Biological), and an MPhil in Biotechnology, both from the University of Cambridge. Her MPhil research investigated the genetic basis for the microbial degradation of cocaine.

Specialisms

  • Life sciences

Industries

  • Agrochemicals icon Agrochemicals
  • Healthcare icon Healthcare
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Patent term extensions & SPCs
  • Patents
  • Portfolio management

Qualifications

Patent Attorney

Chartered (UK)
European


MA

Natural Sciences (Cantab)

OTHER

MPhil Biotechnology (Cantab)

POSTGRADUATE DIPLOMA OR CERTIFICATE

Queen Mary and Westfield College Certificate in Intellectual Property Law

Publications

EU SPC waiver for generic pharmaceuticals producers

View publication online

Conferences: 2020

November 17th 2020

2020 CIPA Life Sciences Webinar Series (2020 CIPA Life Sciences Conference)

Attended

Related News

Event - 7th October 2021

The Business of Science Conference 2021

HGF is sponsoring The Business of Science Conference 2021 on 7th October. Science and the commercialisation of science continues to be fundamental to the economic growth of the UK and …

Event details

IAM Strategy 300 2021

IAM Strategy 300 Global Leaders guide has been published and HGF is delighted to have 4 Partners listed. The guide draws from the worlds of private practice, consulting and other …

Read article
Event - 20th September 2021

German Biotechnology days 2021

HGF’s Partner Dr Markus Zoller is attending and speaking at the German Biotechnology days on 20th September 2021. German Biotechnology days is the go to event in the industry and …

Event details
Event - 9th September 2021

Autonomous Vehicles Expo 2021

HGF is sponsoring the Autonomous Vehicles Expo which is being held on 9th September. Autonomous Vehicles Expo will provide key insights from industry experts on how disruptive technological advances will …

Event details

Decision of the EBoA regarding G1/21

Oral proceedings by videoconference can be enforced by the EPO during the pandemic On 16 July 2021 the EPO’s Enlarged Board of Appeal (EBoA) decided on referral G 1/21 regarding …

Read article
Event - 29th July 2021

HGF and Shiga webinar: Patenting sports and fitness technology in Europe and Japan

HGF in Europe and Shiga in Japan are holding a joint webinar on 29th July 2021. Fitter, faster, stronger – patenting sports and fitness technology in Europe and Japan Sporting …

Event details

IAM Patent 1000 2021

The IAM Patent 1000 – the world’s leading patent professionals 2021 guide has now been published. HGF has 18 European attorneys listed. IAM Patent 1000 is a unique guide that …

Read article
Event - 20th July 2021

WIPR Patents Live webinar: Protecting medical devices in Europe—avoiding common pitfalls

WIPR Patents Live is holding a complimentary session on July 20, at 5pm BST/12pm ET, where HGF Partner & Patent Attorney Kieran Killough will present on ‘Protecting medical devices in …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.